Patents by Inventor Sarfaraz K. Niazi

Sarfaraz K. Niazi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110201050
    Abstract: Fine gas bubbles traveling at fast speed are employed to scrub a hard-surface filter for harvesting liquids from suspensions including those consisting of nutrient media and cell culture, on a continuous basis without clogging the filters.
    Type: Application
    Filed: April 26, 2011
    Publication date: August 18, 2011
    Applicant: Therapeutic Proteins Inc.
    Inventor: Sarfaraz K. Niazi
  • Publication number: 20110117538
    Abstract: Bioreactors suitable for housing a predetermined volume of liquid comprising nutrient medium and biological culture comprising: (a) a container having at least one interior wall; (b) at least one nutrient medium inlet; (c) at least one liquid outlet; (d) at least one gas inlet; (e) at least one gas outlet; and (f) at least one cylindrical sparging filter attached to the at least one gas inlet, wherein the sparging filter comprises a plurality of pores along its axis which permit gas to be emitted radially from the sparging filter into the liquid, wherein the diameter of the plurality of pores does not exceed about 50 ?m, and wherein the orientation of the at least one sparging filter within the container provides for immersion of the plurality of pores within the liquid and substantially uniform distribution of emitted gas throughout the liquid, and related methods of using said bioreactors to prepare various biological products.
    Type: Application
    Filed: November 13, 2009
    Publication date: May 19, 2011
    Inventor: Sarfaraz K. Niazi
  • Publication number: 20100261226
    Abstract: Bioreactors suitable for housing a predetermined volume of culture medium comprising a plurality of containers of approximately equal internal volume in which the culture medium resides, wherein the predetermined volume of culture medium is retained in approximately equal amounts within each of the plurality of containers during operation of the bioreactor, and wherein the internal volume of each container is selected so that the amount of culture medium in each container exceeds 50 vol. % of the container internal volume during operation of the bioreactor, and related methods of use.
    Type: Application
    Filed: April 14, 2009
    Publication date: October 14, 2010
    Inventor: Sarfaraz K. Niazi
  • Publication number: 20040253327
    Abstract: This invention provides compositions and methods related to the administration of psyllium husk, Î2-sitosterol, guggul tree extract, guar gum and chromium as a combination to reduce or control blood cholesterol, triglycerides, low density lipoproteins, blood sugar or increasing or controlling high density lipoproteins in a mammal, to reduce arterial plaque build-up, atherosclerosis, in a mammal which may be associated with cardiovascular, cerebrovascular, peripheral vascular, or intestinal vascular disorders.
    Type: Application
    Filed: June 12, 2003
    Publication date: December 16, 2004
    Inventors: Sarfaraz K. Niazi, Anjum Niazi
  • Patent number: 6555118
    Abstract: A pharmaceutical preparation for the treatment of wounds and ulcers in humans and animals and a method of preparation of the same are provided here. The composition consists of an alcoholic extract of Huangqin, Huanglian, Huangbai, Opuntia, Dilong, and &bgr;-sitosterol (from Soybean extract), in a vegetable oil-wax base, from where the alcohol is essentially removed by evaporation. The composition is used as a topical ointment for the treatment of wounds in its preferred embodiment. Wounds, in particular those occurring in the skin as second and third degree burns, stasis ulcers, trophic lesions, such as decubitus ulcers, diabetic ulcers, surgical wounds, severe cuts, diaper rash, cracked nipples and abrasions which are commonly resistant to the natural healing process, may be treated with this composition.
    Type: Grant
    Filed: February 22, 2001
    Date of Patent: April 29, 2003
    Inventor: Sarfaraz K Niazi
  • Publication number: 20030059487
    Abstract: A pharmaceutical composition suitable for the treatment of a condition selected from the group consisting of atherosclerosis, post-angioplasty restenosis, coronary artery disease, angina, small artery disease and other diseases caused by or are the result of hypercholesterolemia, or combination thereof comprising of a specific botanical plant. Specifically, the present invention relates to compositions comprising the herb or botanical Zizyphus jujube or extract thereof, which is useful in treating cardiovascular disorders, particularly those associated with elevated LDL and overall serum cholesterol levels. A method of preparing the pharmaceutical compositions of the invention and a method for treating a patient therewith are also disclosed.
    Type: Application
    Filed: September 21, 2001
    Publication date: March 27, 2003
    Inventor: Sarfaraz K. Niazi
  • Patent number: 6495174
    Abstract: Described here a composition comprising of alcoholic extracts of herbs RHIZOMA ZINGIBERIS RECENS, RHIZOMA PINELLIAE, FLOS CARTHAMI, RADIX REHMANNIAE, RADIX ANGELICAE SINESIS, RADIX PAENOIAE RUBRA, CACUMEN BIOTAE, SEMEN SESAMI NIGRUM, RADIX POLYGONI MULTIFLORI, FRUCTUS MORI combined with TINCTURE CAPSICUM, TINCTURE CANTHARIDINATE, and OLEUM RICINI for direct application to scalp for the treatment of all kinds of alopecia in humans. Alternately, the herbs listed here can be used individually.
    Type: Grant
    Filed: February 21, 2001
    Date of Patent: December 17, 2002
    Inventor: Sarfaraz K. Niazi
  • Publication number: 20020183297
    Abstract: Pharmaceutical compositions containing phystosterols and/or blood flow stimulants are described to promote hair growth through stimulation of follicular cells, bulb cells and stem cells in the scalp to treat the condition of alopecia in humans and animals.
    Type: Application
    Filed: February 15, 2002
    Publication date: December 5, 2002
    Inventor: Sarfaraz K. Niazi
  • Patent number: 6462083
    Abstract: This invention provides a suppository base composition of erucic acid and beeswax with improved chemical stability, moldability, and shelf-life. The inventive suppository base also stimulates localized blood flow to the administration site.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: October 8, 2002
    Inventor: Sarfaraz K. Niazi
  • Patent number: 6447820
    Abstract: The disclosed is a treatment of existing and prevention of new skin scars in humans and animals using a topical application containing alcoholic extracts of Cortex Phellodendri and Opuntia ficus indica in a specific combination.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: September 10, 2002
    Inventor: Sarfaraz K Niazi
  • Patent number: 6419963
    Abstract: Provided here is a pharmaceutical composition containing beeswax, olive oil, &bgr;-sitosterol and the herb Coptis chinesis Franch for safe and quick treatment for infant and adult diaper rash. Also provided here is a methodology for the treatment of diaper rash wherein the treatment consists of compositions that contain naturally derived anti-inflammatory agents, an antimicrobial agents and such components that they provide an occlusive coating when applied to the afflicted surface.
    Type: Grant
    Filed: April 22, 2001
    Date of Patent: July 16, 2002
    Inventor: Sarfaraz K Niazi
  • Patent number: 6365198
    Abstract: A pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids in humans and animals and a method of preparation for this composition are provided here. The preferred composition consists of an alcoholic extract of Huangqin, Huanglian, Huangbo, Opuntia and Pheretima dissolved in vegetable oil from where alcohol is essentially removed by evaporation. The composition is then packaged in a soft gelatin capsule for oral administration or mixed with wax to make an ointment suitable for rectal administration.
    Type: Grant
    Filed: January 28, 2001
    Date of Patent: April 2, 2002
    Assignee: Gulf Pharmaceutical Industries
    Inventor: Sarfaraz K. Niazi
  • Patent number: 6338862
    Abstract: The inhibitors of cyclic guanosine monophosphate (cGMP) phosphodiesterases type 5 (cGMP-PDE5) such as sildenafil citrate (Viagra®) act by increasing the level of cGMP in sexual organs to produce enhanced blood flow and an erectile response of sexual organs. Though sildenafil citrate is a specific inhibitor of cGMP-PDE5, its effects on other body organs produce many side effects including fatalities. Described here is a method of combining cGMP-PDE5 inhibitors with natural sources of nutrients that instantly enhance the levels of endogenous cGMP and thus reduce the therapeutic dose and therefore the side effects of cGMP-PDE5 inhibitors. We have discovered that if sildenafil citrate, as a prototype of cGMP-PDE5, is combined with L-arginine, ginseng, vitamin B6, vitamin B12, and folic acid, all natural and safe ingredients, the dose requirements for sildenafil citrate can be reduced substantially.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: January 15, 2002
    Inventor: Sarfaraz K Niazi
  • Patent number: 6312735
    Abstract: Disclosed here is a method for the removal of all types of human and animal skin warts using a technique of cauterization wherein slaked lime is applied to wart and then the surface of wart is scratched by using the stem of betel leaf.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: November 6, 2001
    Inventors: Sarfaraz K. Niazi, Riaz K. Niazi
  • Patent number: 6251421
    Abstract: The present invention provides orally administrable pharmaceutical compositions containing an inhibitor of gastrointestinal lipase, and at least one compound selected from the group consisting of psyllium husk, its seeds and leaves thereof. Methods are provided for preventing and treating anal leakage of oil in a patient to whom a composition containing an inhibitor of gastrointestinal lipase is orally administered.
    Type: Grant
    Filed: September 25, 2000
    Date of Patent: June 26, 2001
    Inventor: Sarfaraz K. Niazi
  • Patent number: 6235796
    Abstract: Method for the prevention and inhibition of adhesion between tissues comprising the use of fluorocarbons are disclosed. The method provides for the introduction of a fluorocarbon into the surgical site of a mammalian body, such as a human, to minimize friction and enhance the mobility of the surrounding tissues and organs. The fluorocarbons introduced may be in various forms including liquid and emulsions, and provides a coating, film or barrier thereby reducing the surface tension associated after surgery. The subject invention further discloses the use of perfluorodecalin as a preferred fluorocarbon compound used as the primary anti-adhesion agent.
    Type: Grant
    Filed: June 26, 2000
    Date of Patent: May 22, 2001
    Inventor: Sarfaraz K. Niazi
  • Patent number: 6235314
    Abstract: Disclosed is a local skeletal muscle relaxant and a non-steroidal anti-inflammatory drug in a topical composition for topical application to a patient for relief of pain. More particularly and in its preferred form, the invention involves a combination of diazepam and diclofenac in a composition for topical application to the skin of a patient as a colorless transparent gel.
    Type: Grant
    Filed: August 8, 2000
    Date of Patent: May 22, 2001
    Inventor: Sarfaraz K. Niazi